Dutch Asset Corp’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Dutch Asset Corp’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$597K	Sell	3,773 -350	-8%	-$47.3K	0.3%	48
2026 Q1	$527K	Sell	4,123 -200	-5%	-$25K	0.35%	48
2025 Q4	$527K	Buy	+4,323	New	+$496K	0.41%	51

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Dutch Asset Corp's XBI Position: Q2 2026 in Review

Dutch Asset Corp reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 8.5% in Q2 2026, selling an estimated $47.3K and leaving 3,773 shares worth $597K. The position accounts for 0.3% of the portfolio, ranked #48.

Dutch Asset Corp first reported a position in XBI in Q4 2025 and has held it in 3 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Dutch Asset Corp held 3,773 shares of State Street SPDR S&P Biotech ETF worth $597K as of Q2 2026.
Dutch Asset Corp sold 350 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $47.3K.
State Street SPDR S&P Biotech ETF made up 0.3% of Dutch Asset Corp's portfolio in Q2 2026, its #48 holding.
Dutch Asset Corp first reported a position in State Street SPDR S&P Biotech ETF in Q4 2025 and has held it in 3 quarters since.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Dutch Asset Corp's 13F filing for Q2 2026, filed 10 Aug 2026.